Deals of the Week: Ante Up For Antisense, Pharma Places Another Isis Bet
(Source: InVivoBlog) … proceeds from equity sales or $784 million borrowed in long-term debt deals. … it brings to the table Isis’ antisense oligonucleotide technology (ASO), as well …